相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
Ping Mei et al.
DIAGNOSTIC PATHOLOGY (2020)
The regulatory network behind MHC class I expression
Marlieke L. M. Jongsma et al.
MOLECULAR IMMUNOLOGY (2019)
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O. Hamid et al.
ANNALS OF ONCOLOGY (2019)
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide et al.
CANCER CELL (2019)
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Ziduo Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu et al.
NATURE (2018)
CD83 expression is essential for Treg cell differentiation and stability
Marina Doebbeler et al.
JCI INSIGHT (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The use of immunotherapy in the treatment of melanoma
Tala Achkar et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing
Sylvain Mareschal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
Jennifer D. Hintzsche et al.
MELANOMA RESEARCH (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
J. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
Beryl Royer-Bertrand et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
Larry Mansouri et al.
BLOOD (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples
Jennifer Hintzsche et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Signaling via the NFκB system
Simon Mitchell et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Larry Mansouri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A. Hunter Shain et al.
NATURE GENETICS (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
NF-κB and the cell cycle
Adeline C. Ledoux et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Somatic Mutations in MAP3K5 Attenuate Its Proapoptotic Function in Melanoma through Increased Binding to Thioredoxin
Todd D. Prickett et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Differential analysis of gene regulation at transcript resolution with RNA-seq
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2013)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
SIFT web server: predicting effects of amino acid substitutions on proteins
Ngak-Leng Sim et al.
NUCLEIC ACIDS RESEARCH (2012)
Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in Japanese
Keiko Myouzen et al.
PLOS GENETICS (2012)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Local secretion/shedding of tumor-derived CD83 molecules as a novel tumor escape mechanism
R. B. Baleeiro et al.
MOLECULAR IMMUNOLOGY (2008)
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas
Minh Quang Huynh et al.
LEUKEMIA & LYMPHOMA (2008)
Activation of the cyclin D2 and cdk6 genes through NF-κB is critical for cell-cycle progression induced by HTLV-I Tax
R. Iwanaga et al.
ONCOGENE (2008)
Expression of a dendritic cell maturation marker CD83 on tumor cells from lung cancer patients and several human tumor cell lines: is there a biological meaning behind it?
R. B. Baleeiro et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Activation of NF-κB by the intracellular expression of NF-κB-inducing kinase acts as a powerful vaccine adjuvant
E. Andreakos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity
N Hirano et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IκB kinases:: key regulators of the NF-κB pathway
Y Yamamoto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford et al.
BRITISH JOURNAL OF CANCER (2004)
Cloning and characterization of the promoter region of the human CD83 gene
S Berchtold et al.
IMMUNOBIOLOGY (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
分享论文
